Valuation: Enovis Corporation

Market Cap 1.07B 956M 888M 808M 1.52B 101B 1.55B 10.67B 4.18B 52.92B 4.02B 3.93B 169B P/E 2026 *
91.9x
P/E 2027 * 28.4x
Enterprise Value 2.38B 2.12B 1.97B 1.79B 3.37B 225B 3.44B 23.69B 9.27B 117B 8.92B 8.73B 376B EV / Sales 2026 *
1.02x
EV / Sales 2027 * 0.94x
Free-Float
98.36%
Yield 2026 *
-
Yield 2027 * -
1 day+4.20%
1 week+11.02%
Current month+5.91%
1 month+7.86%
3 months-24.38%
6 months-23.61%
Current year-27.36%
1 week 17.14
Extreme 17.145
19.44
1 month 16.7
Extreme 16.7
19.44
Current year 16.7
Extreme 16.7
31.66
1 year 16.7
Extreme 16.7
34.28
3 years 16.7
Extreme 16.7
65.03
5 years 16.7
Extreme 16.7
164.01
10 years 16.7
Extreme 16.7
164.01
Manager TitleAgeSince
Chief Executive Officer 61 2025-05-11
Director of Finance/CFO 47 2022-12-31
Chief Tech/Sci/R&D Officer - 2025-12-31
Director TitleAgeSince
Director/Board Member 55 2008-05-12
Director/Board Member 67 2010-09-20
Chairman 64 2025-05-20
Date Insider Type Main position Quantity % Market Cap. Importance
9/30/26 Free

Director

958 0.0017%
9/4/26 Buy

Chief Administrative Officer

2,660 0.0047%
9/4/26 Buy

Chief Executive Officer

13,035 0.0228%
Change 5-day change 1-year change 3-year change Capi.($)
+4.20%+11.02%-37.96%-60.18% 1.07B
+2.29%+6.28%-19.13%+13.56% 178B
+1.29%+8.77%+0.12%+33.03% 121B
+4.12%+5.87%-20.70%+11.03% 108B
+0.41%+1.40%-45.37%-9.38% 75.7B
+1.56%+6.24%+6.82%+82.71% 64.15B
-1.75%-0.72%+17.66%+59.66% 53.49B
+2.58%+6.02%+3.74%-25.41% 51.45B
+3.43%+6.63%-14.39%+27.38% 41.68B
+5.08%+3.91%+34.09%+11.10% 31.5B
Average +2.35%+3.69%-7.51%+14.35% 72.58B
Weighted average by Cap. +1.96%+4.21%-9.72%+21.35%

Financials

2026 *2027 *
Net sales 2.34B 2.09B 1.94B 1.77B 3.32B 222B 3.38B 23.31B 9.12B 116B 8.78B 8.59B 370B 2.45B 2.19B 2.04B 1.85B 3.48B 232B 3.55B 24.45B 9.57B 121B 9.21B 9.01B 388B
Net income 11.38M 10.15M 9.44M 8.58M 16.15M 1.08B 16.44M 113M 44.35M 562M 42.69M 41.78M 1.8B 29.72M 26.53M 24.66M 22.43M 42.2M 2.82B 42.96M 296M 116M 1.47B 112M 109M 4.7B
Net Debt 1.31B 1.17B 1.08B 986M 1.85B 124B 1.89B 13.02B 5.09B 64.55B 4.9B 4.8B 207B 1.25B 1.11B 1.03B 940M 1.77B 118B 1.8B 12.41B 4.85B 61.53B 4.67B 4.57B 197B
Projected Income Statement - Annual - Enovis Corporation
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
26-10-15 US$19.35 +4.20% 1,246,981
26-10-14 US$18.57 -2.21% 1,142,268
26-10-13 US$18.99 +4.05% 1,405,755
26-10-12 US$18.25 +3.17% 910,923
26-10-09 US$17.69 +1.49% 1,146,638
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Enovis Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
18.57USD
Average target price
36.08USD
Spread / Average Target
+94.31%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Enovis Corporation
  1. Stock Market
  2. Stocks
  3. ENOV Stock